From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare Matthijs VersteeghSaskia KniesWerner Brouwer Editorial 09 September 2016 Pages: 1071 - 1074
Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation Padraig DixonGeorge Davey SmithWilliam Hollingworth Practical Application Open access 02 August 2016 Pages: 1075 - 1086
Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies Feng XieBruno KovicCamila Silvestre Systematic Review 23 June 2016 Pages: 1087 - 1100
The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence Eleftherios SiderisMark CorbettLaura Bojke Review Article 08 June 2016 Pages: 1101 - 1110
A Methodological Review of US Budget-Impact Models for New Drugs Josephine MauskopfStephanie Earnshaw Review Article 22 June 2016 Pages: 1111 - 1131
Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis Matthijs Versteegh Original Research Article Open access 09 June 2016 Pages: 1133 - 1144
Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK Jamie ElvidgeAsh BullementAnthony J. Hatswell Original Research Article 18 June 2016 Pages: 1145 - 1159
Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations Cynthia P. IglesiasAlexander ThompsonKatherine Payne Original Research Article 30 June 2016 Pages: 1161 - 1172
Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience François BocquetAnaïs LoubièrePascal Paubel Original Research Article 13 July 2016 Pages: 1173 - 1186
Discretely Integrated Condition Event Simulation for Pharmacoeconomics Mondher ToumiEkkehard BeckSamuel Aballéa Letter to the Editor 14 September 2016 Pages: 1187 - 1188
Response to Letter to the Editor Regarding Discretely Integrated Condition Event Simulation for Pharmacoeconomics J. Jaime Caro Letter to the Editor 12 September 2016 Pages: 1189 - 1190